Jump Financial LLC Sells 81,867 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Jump Financial LLC cut its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 96.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,189 shares of the medical device company's stock after selling 81,867 shares during the quarter. Jump Financial LLC's holdings in Cooper Companies were worth $293,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Byrne Asset Management LLC acquired a new stake in Cooper Companies during the fourth quarter worth approximately $33,000. OFI Invest Asset Management bought a new stake in Cooper Companies during the fourth quarter worth $34,000. New Age Alpha Advisors LLC acquired a new stake in Cooper Companies in the fourth quarter valued at about $38,000. Covestor Ltd grew its holdings in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC bought a new stake in shares of Cooper Companies during the fourth quarter worth about $49,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on COO shares. Robert W. Baird reduced their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Citigroup cut their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Piper Sandler reiterated an "overweight" rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Finally, Stifel Nicolaus cut their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Trading Up 0.9 %

NASDAQ:COO traded up $0.73 during trading hours on Friday, reaching $81.87. The company's stock had a trading volume of 271,744 shares, compared to its average volume of 1,423,945. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a 50-day simple moving average of $81.60 and a 200-day simple moving average of $92.09. The firm has a market capitalization of $16.37 billion, a price-to-earnings ratio of 41.96, a PEG ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.